Medical News

RSS

Experts to discuss employee health care benefits in BNA Tax & Accounting webinar

When President Obama signed the Patient Protection and Affordable Care Act into law, he ushered in dramatic health care reforms unparalleled since the days of Franklin Delano Roosevelt's New Deal. On April 8, two of the nation's foremost employee benefits and health care law experts from Sonnenschein Nath & Rosenthal LLP, Bruce Fried and Martin Moderson, will present a BNA Tax & Accounting webinar, Health Care Reform – Preparing Employers and Health Plans, directed to professionals who advise employers large and small on employee health care benefits or work with ERISA or non-ERISA health plans.

31 Mar 2010

STAAR Surgical Company enters into 'Stipulation for Settlement' to resolve pending disputes

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that STAAR and all other parties to the matters Parallax Medical Systems v. STAAR Surgical Company and Scott C. Moody, Inc. v. STAAR Surgical Company entered into a Stipulation for Settlement that globally resolves all pending disputes among them.

31 Mar 2010

Investment report on Sunesis Pharmaceuticals

StockPreacher.com announces an investment report featuring Sunesis Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

31 Mar 2010

GSK, Isis Pharmaceuticals collaborate to develop new therapeutics for rare and serious disease

GlaxoSmithKline and Isis Pharmaceuticals, Inc. announced today a new strategic alliance that will apply the Isis antisense drug discovery platform to seek out and develop new therapeutics against targets for rare and serious disease, including infectious diseases and some conditions causing blindness.

31 Mar 2010

Tongjitang Chinese Medicines' net revenue rises 31.5% in fourth quarter 2009

Tongjitang Chinese Medicines Company, a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced its financial results for the fourth quarter of 2009 and for the full year ended December 31, 2009.

31 Mar 2010

Panel of experts endorse effectiveness of Mirasol PRT System for preventing GVHD

CaridianBCT, a leading global provider of technology, products and services in the blood banking, transfusion medicine and cell therapy industries, today announced that a panel of medical and scientific experts have endorsed the effectiveness of the Mirasol® Pathogen Reduction Technology System for replacing gamma irradiation, the current standard of care for preventing transfusion-related Graft vs. Host Disease in platelet recipients.

31 Mar 2010

First Edition: March 31, 2010

According to today's headlines, just as President Obama signed the last piece of the health overhaul into law, the U.S. Chamber of Commerce launched efforts to shape its regulatory language. Meanwhile, analysis of particular policies included in the sweeping measure continue.

31 Mar 2010

Advanced Instruments launches three new levels of Osmometer Standard Solutions

Advanced Instruments is pleased to introduce three new levels of Osmometer Standard Solutions to its product offering. The 200, 400 and 1000 mOsm/kg H20 level standards are NIST- traceable salt solutions that are packaged in 2mL ampules, 10 ampules per box. The kits are available for immediate release.

31 Mar 2010

Cancer Research UK launches three new prestigious awards to recognise cancer researchers

CANCER RESEARCH UK today (Tuesday) announced the launch of three new prestigious awards that will recognise world leading cancer researchers and the scientists of tomorrow.

31 Mar 2010

Indispensable role of Mindin in innate and adaptive immunity

Mindin has an indispensable role in both innate and adaptive immunity. A research group in China investigated regulation of mindin expression and the signaling pathway involved. mRNA expression of mindin was upregulated during dextran sulfate sodium induced mouse intestinal inflammation. Stimulation with CpG-ODN (a known TLR-9 ligand) induced upregulation of mindin expression in RAW 264.7 cells and significantly increased the NF-κB-luciferase activity in vitro.

31 Mar 2010

SCYNEXIS presents overview of novel cyclophilin inhibitor at Hepatitis C Conference

Drug discovery company, SCYNEXIS, Inc. announced today that management will present an overview on the Company's lead anti-hepatitis C virus (HCV) candidate, SCY-635, at the upcoming Canaccord Adams' Hepatitis C Conference on Thursday, April 1, 2010 at 11:15 am ET at the Peninsula Hotel in New York City.

31 Mar 2010

Bayat Foundation inaugurates construction of Gawhartaj Bayat maternity hospital in Afghanistan

In a country that leads in infant mortality rates, the Bayat Foundation inaugurated the construction of a maternity hospital in a ceremony with local officials. Named "Gawhartaj Bayat", this much needed facility will accommodate space for 20 beds, a pharmacy, laboratory, and include modern equipment. The project is scheduled to be complete and open for care by October 1, 2010 in Gardez, the capital of the southeast province of Paktia in Afghanistan.

31 Mar 2010

In-depth practitioner training and experience critical for successful dental implant procedure

Burgeoning consumer demand for dental implants has prompted dentists nationwide to add implants to their practices, and some have mounted aggressive advertising campaigns to promote implants to consumers. But how can patients objectively evaluate the qualifications of a dentist to perform implant surgery?

31 Mar 2010

Vidazorb probiotic supplements could minimize severity of IBS symptoms

April is Irritable Bowel Syndrome (IBS) Awareness Month. IBS is a chronic condition affecting between 15 and 20 percent of all adults in the Western world. However, IBS is difficult to identify due to the numerous symptoms associated with it. Almost 40 percent of IBS sufferers report symptoms severe and frequent enough to disrupt their daily lives, making it is a serious issue—one to which Vidazorb® probiotic supplements may offer some relief.

31 Mar 2010

Versar awarded $7.6M contract to review and evaluate pesticide product

Versar, Inc. announced today that it was awarded a five-year, $7.6 million contract to review and evaluate pesticide product and residue chemistry data by the Office of Pesticide Programs, Health Effects Division, of the U.S. Environmental Protection Agency.

31 Mar 2010

Lorillard Tobacco issues statement on FDA's TPSAC public meeting

Lorillard Tobacco Company today issued the following statement regarding the Food and Drug Administration's Tobacco Products Scientific Advisory Committee which is holding its first public meeting this week.

31 Mar 2010

Eisai Europe seeks EMA approval of eribulin mesylate for locally advanced or metastatic breast cancer

Eisai Europe Ltd. today announced that it has submitted a marketing authorization application to the European Medicines Agency (EMA) for approval of eribulin mesylate, also known as 'E7389', for the treatment of locally advanced or metastatic breast cancer in Europe. Eribulin mesylate, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai. Regulatory applications for eribulin mesylate have also been submitted in the United States and Japan.

31 Mar 2010

Feinstein Institute scientists seek sisters for lupus study

The SisSLE (Sisters of Women with Systemic Lupus Erythematosus) research study is looking for sisters: one with a diagnosis of systemic lupus erythematosus (SLE), an autoimmune disease and one (or more) who does not have lupus.

31 Mar 2010

PhRMA report: 234 medicines in development for special health care needs of children

America's pharmaceutical research and biotechnology companies are developing 234 medicines for the special health care needs of children, according to a new report released today by the Pharmaceutical Research and Manufacturers of America.

31 Mar 2010

Hepatectomy effective for treatment of caudate lobe HCC

Caudate hepatocellular carcinoma (HCC) has a poorer prognosis than HCC originating from other lobes, due to its proximity to the portal trunk and inferior vena cava, which facilitate intrahepatic and systemic spread early in the disease. Hepatic resection is considered, in principle, to be the first choice treatment. In order to improve surgical outcome, it is necessary to evaluate the potential risk factors affecting long-term survival and to establish guidelines for the appropriate use of hepatectomy for caudate lobectomy.

31 Mar 2010

Medical News

Experts to discuss employee health care benefits in BNA Tax & Accounting webinar

STAAR Surgical Company enters into 'Stipulation for Settlement' to resolve pending disputes

Investment report on Sunesis Pharmaceuticals

GSK, Isis Pharmaceuticals collaborate to develop new therapeutics for rare and serious disease

Tongjitang Chinese Medicines' net revenue rises 31.5% in fourth quarter 2009

Panel of experts endorse effectiveness of Mirasol PRT System for preventing GVHD

First Edition: March 31, 2010

Advanced Instruments launches three new levels of Osmometer Standard Solutions

Cancer Research UK launches three new prestigious awards to recognise cancer researchers

Indispensable role of Mindin in innate and adaptive immunity

SCYNEXIS presents overview of novel cyclophilin inhibitor at Hepatitis C Conference

Bayat Foundation inaugurates construction of Gawhartaj Bayat maternity hospital in Afghanistan

In-depth practitioner training and experience critical for successful dental implant procedure

Vidazorb probiotic supplements could minimize severity of IBS symptoms

Versar awarded $7.6M contract to review and evaluate pesticide product

Lorillard Tobacco issues statement on FDA's TPSAC public meeting

Eisai Europe seeks EMA approval of eribulin mesylate for locally advanced or metastatic breast cancer

Feinstein Institute scientists seek sisters for lupus study

PhRMA report: 234 medicines in development for special health care needs of children

Hepatectomy effective for treatment of caudate lobe HCC

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News